• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPD 患者住院利用率的逐年变化趋势:一项真实世界、单中心、回顾性队列研究。

Year-to-year trajectories of hospital utilisation rates among patients with COPD: a real-world, single-centre, retrospective cohort study.

机构信息

Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore

Value Evidence and Outcomes, GSK, Greater China and Intercontinental, Singapore.

出版信息

BMJ Open. 2023 Sep 1;13(9):e072571. doi: 10.1136/bmjopen-2023-072571.

DOI:10.1136/bmjopen-2023-072571
PMID:37657841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10476133/
Abstract

OBJECTIVES

The long-term clinical trajectory of chronic obstructive pulmonary disease (COPD) in terms of year-to-year hospital utilisation rates can be highly variable and is not well studied. We investigated year-to-year trends of hospitalisation or emergency department (ED) visits among patients with COPD over 3 years, identified distinct trajectories and examined associated predictive factors.

DESIGN

A retrospective cohort study.

SETTING

Data were extracted from the Changi General Hospital, Singapore COPD data warehouse.

PARTICIPANTS

Patients with COPD aged ≥40 years with 3 years of follow-up data.

PRIMARY AND SECONDARY OUTCOME MEASURES

The yearly rates of hospitalisations or ED visits, stratified by COPD-related or all-cause, were described. Group-based trajectory modelling was used to identify clinically distinct trajectories year-by-year. Baseline predictive factors associated with different trajectories were examined.

RESULTS

In total, 396 patients were analysed (median age 70 years; 87% male). Four trajectories were generated for year-to-year trends in COPD-related hospitalisations/ED visits (C1-C4: consistently frequent, consistently infrequent, improving and worsening); post-bronchodilator forced expiratory volume in 1 second (FEV) was a significant predictor of trajectory, with worse lung function being the main factor associated with less favourable trajectories. For all-cause hospitalisations/ED visits, four trajectories were identified (A1-A4: infrequent and stable, frequent and stable, frequent and decreasing, frequent and increasing); significant differences in age (p=0.041), sex (p=0.016) and ethnicity (p=0.005) were found between trajectories. Higher overall comorbidity burden was a key determinant in less favourable trajectories of all-cause hospitalisations/ED visits.

CONCLUSIONS

Distinct trajectories were demonstrated for hospitalisations/ED visits related to COPD or all causes, with predictive associations between FEV and COPD trajectory and between comorbidities and all-cause trajectory. Trajectories carry nuanced prognostic information and may be useful for clinical risk stratification to identify high-risk individuals for preventative treatments.

摘要

目的

慢性阻塞性肺疾病(COPD)的长期临床轨迹表现在逐年的住院利用率上可能存在高度变异性,目前对此研究甚少。我们调查了 3 年内 COPD 患者的住院或急诊(ED)就诊的逐年趋势,确定了不同的轨迹,并研究了相关的预测因素。

设计

回顾性队列研究。

地点

数据来自新加坡樟宜综合医院 COPD 数据仓库。

参与者

年龄≥40 岁,有 3 年随访数据的 COPD 患者。

主要和次要观察指标

描述 COPD 相关或全因住院或 ED 就诊的逐年发生率。采用基于群组的轨迹建模方法,逐年确定临床明显的轨迹。检查与不同轨迹相关的基线预测因素。

结果

共分析了 396 例患者(中位年龄 70 岁,87%为男性)。根据 COPD 相关住院/ED 就诊的逐年趋势,共产生了 4 种轨迹(C1-C4:持续频繁、持续不频繁、改善和恶化);支气管扩张剂后 1 秒用力呼气量(FEV1)是轨迹的重要预测因素,肺功能越差与较差的轨迹相关。对于全因住院/ED 就诊,确定了 4 种轨迹(A1-A4:不频繁且稳定、频繁且稳定、频繁且减少、频繁且增加);在轨迹之间发现了年龄(p=0.041)、性别(p=0.016)和种族(p=0.005)的显著差异。整体合并症负担较高是全因住院/ED 就诊较差轨迹的关键决定因素。

结论

COPD 相关或全因住院/ED 就诊的轨迹存在明显差异,FEV1 与 COPD 轨迹之间以及合并症与全因轨迹之间存在预测关联。轨迹携带细微的预后信息,可用于临床风险分层,以识别高危个体进行预防性治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966e/10476133/b2254fc34730/bmjopen-2023-072571f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966e/10476133/0dd48344d454/bmjopen-2023-072571f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966e/10476133/a5f240ffe6a6/bmjopen-2023-072571f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966e/10476133/b2254fc34730/bmjopen-2023-072571f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966e/10476133/0dd48344d454/bmjopen-2023-072571f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966e/10476133/a5f240ffe6a6/bmjopen-2023-072571f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/966e/10476133/b2254fc34730/bmjopen-2023-072571f03.jpg

相似文献

1
Year-to-year trajectories of hospital utilisation rates among patients with COPD: a real-world, single-centre, retrospective cohort study.COPD 患者住院利用率的逐年变化趋势:一项真实世界、单中心、回顾性队列研究。
BMJ Open. 2023 Sep 1;13(9):e072571. doi: 10.1136/bmjopen-2023-072571.
2
Quantifying sustained health system benefits of primary care-based integrated disease management for COPD: a 6-year interrupted time series study.量化基于初级保健的综合疾病管理对 COPD 的持续卫生系统效益:一项 6 年的中断时间序列研究。
Thorax. 2024 Jul 16;79(8):725-734. doi: 10.1136/thorax-2023-221211.
3
Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).慢性阻塞性肺疾病的就诊情况及其预测因素:一项使用美国国家急诊科样本(NEDS)的研究。
Respir Res. 2016 Jan 6;17:1. doi: 10.1186/s12931-015-0319-y.
4
Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.儿童时期肺功能轨迹与未来 COPD 风险的预测因素:一项前瞻性队列研究,从生命的第一个十年到第六个十年。
Lancet Respir Med. 2018 Jul;6(7):535-544. doi: 10.1016/S2213-2600(18)30100-0. Epub 2018 Apr 5.
5
Population-based burden of COPD-related visits in the ED: return ED visits, hospital admissions, and comorbidity risks.基于人群的 ED 中 COPD 相关就诊负担:再就诊 ED、住院和合并症风险。
Chest. 2013 Sep;144(3):784-793. doi: 10.1378/chest.12-1899.
6
Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.长期护理机构中医疗保险受益人的慢性阻塞性肺疾病负担
Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.
7
Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.与异丙托溴铵相比,使用丙酸氟替卡松500微克/沙美特罗50微克进行初始维持治疗的老年人慢性阻塞性肺疾病住院/急诊就诊风险及治疗费用。
Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005.
8
Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture.髋部骨折后老年人潜在可预防住院的基于群组的轨迹。
Osteoporos Int. 2024 Oct;35(10):1849-1857. doi: 10.1007/s00198-024-07203-4. Epub 2024 Jul 31.
9
Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.肺功能对慢性阻塞性肺疾病患者急性加重、医疗保健利用及费用的影响。
Int J Chron Obstruct Pulmon Dis. 2016 Jul 27;11:1689-703. doi: 10.2147/COPD.S108967. eCollection 2016.
10
Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.基于人群的 1 年匹配队列研究:布地奈德/福莫特罗和丙酸氟替卡松/沙美特罗对慢性阻塞性肺疾病(COPD)患者的相对有效性:对 COPD 加重、急诊就诊和住院、药物使用和治疗依从性的影响。
Clin Ther. 2010 Jul;32(7):1320-8. doi: 10.1016/j.clinthera.2010.06.022.

本文引用的文献

1
Longitudinal FEV and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling.COPD 患者的纵向 FEV 和加重风险:使用联合建模定量评估相关性。
Int J Chron Obstruct Pulmon Dis. 2021 Jan 15;16:101-111. doi: 10.2147/COPD.S284720. eCollection 2021.
2
The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline.COPD 缓解期治疗中加重事件的长期负担与肺功能下降。
Int J Chron Obstruct Pulmon Dis. 2020 Aug 6;15:1909-1918. doi: 10.2147/COPD.S253812. eCollection 2020.
3
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review.
慢性阻塞性肺疾病(COPD)经济负担:系统文献回顾。
Int J Chron Obstruct Pulmon Dis. 2020 Feb 26;15:439-460. doi: 10.2147/COPD.S234942. eCollection 2020.
4
Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps.肺功能轨迹与慢性阻塞性肺疾病:现有认识与知识缺口
Curr Opin Pulm Med. 2018 Mar;24(2):124-129. doi: 10.1097/MCP.0000000000000456.
5
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.慢性阻塞性肺疾病患者的加重频率:SPIROMICS 队列分析。
Lancet Respir Med. 2017 Aug;5(8):619-626. doi: 10.1016/S2213-2600(17)30207-2. Epub 2017 Jun 28.
6
Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis.慢性阻塞性肺疾病患者共病的患病率:一项荟萃分析。
Medicine (Baltimore). 2017 May;96(19):e6836. doi: 10.1097/MD.0000000000006836.
7
Long-term future risk of severe exacerbations: Distinct 5-year trajectories of problematic asthma.严重急性加重的长期未来风险:问题性哮喘的不同5年轨迹。
Allergy. 2017 Sep;72(9):1398-1405. doi: 10.1111/all.13159. Epub 2017 Apr 25.
8
COPD Readmissions: Addressing COPD in the Era of Value-based Health Care.慢性阻塞性肺疾病再入院:在基于价值的医疗保健时代应对慢性阻塞性肺疾病
Chest. 2016 Oct;150(4):916-926. doi: 10.1016/j.chest.2016.05.002. Epub 2016 May 7.
9
Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey.慢性阻塞性肺疾病(COPD)对亚太地区的影响:基于亚太地区人群的EPIC研究调查
Asia Pac Fam Med. 2015 Apr 23;14(1):4. doi: 10.1186/s12930-015-0020-9. eCollection 2015.
10
Group-based trajectory modeling: an overview.基于群组的轨迹建模:概述
Ann Nutr Metab. 2014;65(2-3):205-10. doi: 10.1159/000360229. Epub 2014 Nov 18.